empagliflozin
boehringer ingelheim,eli lilly
['empa-kidney']
david preiss presenting results of empa-kidney trial #aha22 
Physician, epidemiologist & clinical trialist: https://t.co/PuSJzZsPC6 @oxford_ndph. Lead, Good Clinical Trials Collaborative https://t.co/Do4H97gzf0. CEO https://t.co/4YkPhZtWPG